Literature DB >> 2567343

Cross-reactive immunity among different serotypes of virus causing haemorrhagic fever with renal syndrome.

H Asada1, K Balachandra, M Tamura, K Kondo, K Yamanishi.   

Abstract

Spleen cells primed by Prospect Hill (PH) or Puumala (Pu) virus could cross-react with Hantaan virus (HV) 76-118 strain-infected target cells after in vitro stimulation with HV-infected cells, although anti-PH or anti-Pu immune serum showed no cross-reactive neutralizing (NT) activity to HV without complement. These results and our previous findings with cross-reactive cytotoxic T lymphocytes (CTLs) suggest that some epitopes recognized by CTLs might be common among the hantavirus genus, while the epitopes related to NT activity were mainly specific to each virus of this genus. Next, to evaluate the cross-reactive immunities demonstrated by in vitro study, we investigated the effect of transferring T lymphocytes and sera from BALB/c mice immunized with PH or Pu virus into nude mice before HV inoculation. Transferring T lymphocytes primed by PH or Pu virus reduced HV titres in lungs and spleens of nude mice, corresponding with the results of the in vitro CTL assays. Transferring anti-Pu immune serum also decreased HV titres in nude mice, which seemed to reflect complement-dependent NT activity. Moreover ICR mice previously immunized with PH or Pu virus showed resistance to challenge with a lethal dose of the HV KHF strain, indicating that cross-reactive immunity induced by PH or Pu virus could protect ICR mice against pathogenic HV infection.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2567343     DOI: 10.1099/0022-1317-70-4-819

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  7 in total

1.  Role of peripheral blood mononuclear cell (PBMC) phenotype changes in the pathogenesis of haemorrhagic fever with renal syndrome (HFRS).

Authors:  A Markotić; G Dasić; A Gagro; A Sabioncello; S Rabatić; I Kuzman; R Zgorelec; I Smoljan; I Beus; T A Zupanc; D Dekaris
Journal:  Clin Exp Immunol       Date:  1999-02       Impact factor: 4.330

2.  Human memory cytotoxic T-lymphocyte (CTL) responses to Hantaan virus infection: identification of virus-specific and cross-reactive CD8(+) CTL epitopes on nucleocapsid protein.

Authors:  H L Van Epps; C S Schmaljohn; F A Ennis
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

3.  DNA vaccination with the Hantaan virus M gene protects Hamsters against three of four HFRS hantaviruses and elicits a high-titer neutralizing antibody response in Rhesus monkeys.

Authors:  J W Hooper; D M Custer; E Thompson; C S Schmaljohn
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

4.  Cross-protection against challenge with Puumala virus after immunization with nucleocapsid proteins from different hantaviruses.

Authors:  Cristina de Carvalho Nicacio; Marcelo Gonzalez Della Valle; Paula Padula; Ewa Björling; Alexander Plyusnin; Ake Lundkvist
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

5.  A vaccinia virus-vectored Hantaan virus vaccine protects hamsters from challenge with Hantaan and Seoul viruses but not Puumala virus.

Authors:  Y K Chu; G B Jennings; C S Schmaljohn
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

6.  Protective immunity of Hantaan virus nucleocapsid and envelope protein studied using baculovirus-expressed proteins.

Authors:  K Yoshimatsu; Y C Yoo; R Yoshida; C Ishihara; I Azuma; J Arikawa
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

7.  Appearance of renal hemorrhage in adult mice after inoculation of patient-derived hantavirus.

Authors:  Kenta Shimizu; Takaaki Koma; Kumiko Yoshimatsu; Yoshimi Tsuda; Yuji Isegawa; Jiro Arikawa
Journal:  Virol J       Date:  2017-01-26       Impact factor: 4.099

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.